Desk›Healthcare› Alivus Life Sciences Ltd
Alivus Life Sciences Ltd
BSE 543322 · NSE ALIVUS · ISIN INE03Q201024 · Group A · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹1,351.25
-0.48%
BSE close, 28 August 2026
₹16,589.49 cr
12.3 cr shares · Small cap
₹4,147.62 cr
as published
27.5× · 6.53×
EPS ₹49.13 · BV ₹206.93
2,551.83 / 564.48
₹ cr, as filed
30
7 selected · 23%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -4.6% |
|---|---|
| Against 52-week low | +62.8% |
| Day change | -0.48% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹49.13 |
|---|---|
| Price / earnings | 27.50× |
| Price / book | 6.53× |
| Book value — derived, price ÷ P/B | ₹206.93 |
| Return on equity | 23.76% |
| Operating margin | 36.56% |
| Net margin | 25.00% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 23.75%
- ROE as published
- 23.76%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 640.41 | 160.08 | 13.04 | 36.56% | 25.00% |
| Mar-26 · Q | 689.12 | 162.66 | 13.23 | 34.44% | 23.60% |
| FY25-26 | 2,551.83 | 564.48 | 45.99 | 32.61% | 22.12% |
Quarter on quarter
- Revenue, quarter on quarter
- -7.1%
- Net profit, quarter on quarter
- -1.6%
- Operating margin, quarter on quarter
- +212 bps
Disclosure profile 30 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Press Release | 2 |
| Acquisition | 1 |
| Board Outcome | 1 |
| Concall Transcript | 1 |
| Investor Presentation | 1 |
| Results | 1 |
| Selected sub-total | 7 |
| Procedural | |
| Analyst / Investor Meet | 8 |
| AGM / EGM | 4 |
| General | 3 |
| Newspaper Publication | 2 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| ESOP Allotment | 1 |
| Record Date | 1 |
| Trading Window | 1 |
| Procedural sub-total | 23 |
| Total | 30 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
30 filings · 7 selected · busiest 2026-07-30
Filing rhythm · the twelve most recent
2026-08-132026-10-09
SelectedProcedural
Filings
30 in the window · 3 earlier on record
-
9 October 2026 ·
Announcement Under Regulation 30 Of SEBI (LODR), 2015
Kindly refer the attachment.
Company Update / General View filing →
-
7 October 2026 ·
Announcement Under Regulation 30 Of SEBI (LODR), 2015 - Acquisition.
We would like to inform that the Company has acquired 9.21% stake in Torrent Urja 19 Private Limited.
Company Update / General View filing →
-
16 September 2026 ·
The Company Has Inc orporated A Wholly Owned Subsidiary Company In Brazil.
Please find enclosed herewith intimation with respect to incorporation of wholly owned subsidiary of the Company in Brazil.
Company Update / General View filing →
-
11 September 2026 ·
Analyst / Investor Meet - Intimation
Enclosed please find herewith details of Investor meet.
Company Update / Analyst / Investor Meet View filing →
-
8 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Please find attached herewith Scrutinizer's Report.
AGM/EGM / AGM View filing →
-
8 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Please find attached herewith proceedings of the 15th Annual General Meeting of Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) held on 8th September, 2026.
AGM/EGM / AGM View filing →
-
7 September 2026 ·
Analyst / Investor Meet - Intimation
Enclosed please find herewith details of Investor meet.
Company Update / Analyst / Investor Meet View filing →
-
25 August 2026 ·
Analyst / Investor Meet - Intimation
Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meetings
Company Update / Analyst / Investor Meet View filing →
-
18 August 2026 ·
Press Release / Media Release
Enclosed please find herewith Press Release with respect to Acquisition.
Company Update / Press Release / Media Release View filing →
-
18 August 2026 ·
Acquisition
Enclosed please find herewith intimation pursuant to Regulation 30 of SEBI (LODR), 2015 with respect to acquisition.
Company Update / Acquisition View filing →
-
13 August 2026 ·
Analyst / Investor Meet - Intimation
Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting
Company Update / Analyst / Investor Meet View filing →
-
13 August 2026 ·
Newspaper Publication
Please find enclosed herewith Newspaper Advertisement of Notice of 15th Annual General Meeting and E-Voting information.
Company Update / Newspaper Publication View filing →
-
11 August 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
Please find enclosed herewith the Business Responsibility & Sustainability Report for FY 2025-26
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
11 August 2026 ·
Reg. 34 (1) Annual Report.
Please find enclosed herewith Integrated Annual Report FY 2025-26 under Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Others / Reg. 34 (1) Annual Report View filing →
-
11 August 2026 ·
Notice Of 15Th Annual General Meeting Of The Company For FY 2025-26 As Required Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find attached herewith Notice convening the 15th Annual General Meeting.
AGM/EGM / AGM View filing →
-
7 August 2026 ·
Analyst / Investor Meet - Intimation
Enclosed please find herewith details of investor meet.
Company Update / Analyst / Investor Meet View filing →
-
7 August 2026 ·
Analyst / Investor Meet - Intimation
Please find attached herewith details of Analyst/Investor meet.
Company Update / Analyst / Investor Meet View filing →
-
7 August 2026 ·
Earnings Call Transcript
Please find attached herewith transcript of Earnings call held on 31 July, 2026.
Company Update / Earnings Call Transcript View filing →
-
6 August 2026 ·
Newspaper Publication
Newspaper Advertisement for 15th Annual General Meeting (AGM)
Company Update / Newspaper Publication View filing →
-
6 August 2026 ·
Intimation Of Record Date For Dividend
Intimation of Record date for Dividend.
Corp. Action / Record Date View filing →
-
6 August 2026 ·
Intimation Of 15Th Annual General Meeting And Record Date.
Intimation of 15th Annual General Meeting and Record date.
AGM/EGM / AGM View filing →
-
31 July 2026 ·
Analyst / Investor Meet - Outcome
We hereby confirm that we have uploaded audio recording of the Q1 FY2027 Earnings Call held on July 31, 2026 on the website of the Company.
Company Update / Analyst / Investor Meet View filing →
-
30 July 2026 ·
Allotment of ESOP / ESPS
Enclosed please find herewith intimation with respect to allotment of equity shares under 'Employee Stock Options Scheme, 2021'
Company Update / Allotment of ESOP / ESPS View filing →
-
30 July 2026 ·
Investor Presentation
Enclosed please find herewith Investors Presentation for Q1 FY 2026-27.
Company Update / Investor Presentation View filing →
-
30 July 2026 ·
Press Release / Media Release
Enclosed please find herewith Press Release of the Company for the first quarter ended June 30, 2026.
Company Update / Press Release / Media Release View filing →
-
30 July 2026 ·
Unaudited Financial Results For The First Quarter Ended June 30, 2026.
Enclosed please find herewith unaudited financial results for the first quarter ended June 30, 2026.
Result / Financial Results View filing →
-
30 July 2026 ·
Board Meeting Outcome for Unaudited Financial Results For The First Quarter Ended June 30, 2026
Enclosed please find herewith unaudited financial results for the first quarter ended June 30, 2026.
Board Meeting / Outcome of Board Meeting View filing →
-
23 July 2026 ·
Analyst / Investor Meet - Intimation
Enclosed please find herewith the details of Earnings Call slated for Friday, July 31, 2026 from 8:30 a.m. to 9:30 a.m. (IST), for your information and record.
Company Update / Analyst / Investor Meet View filing →
-
23 July 2026 ·
Closure of Trading Window
Intimation of closure of Trading Window from 1st July, 2026 to 1st August, 2026 (both days inclusive), for the purpose of approval of unaudited financial results for the quarter ended 30th June, 2026.
Insider Trading / SAST / Closure of Trading Window View filing →
-
23 July 2026 ·
Board Meeting Intimation for Considering And Approving Unaudited Financial Results Of The Company For The Quarter Ended 30Th June, 2026.
Alivus Life Sciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Board Meeting / Board Meeting View filing →
RSS feed for Alivus Life Sciences Ltd · the 50 most recent filings